Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

This study is an observational study that retrospectively collects data of triple-negative breast cancer patients who received neoadjuvant therapy. It compares the bpCR rate, apCR rate, and tpCR rate of patients treated with chemotherapy or immunotherapy, in order to analyze the efficacy and influencing factors of chemotherapy and immunotherapy in neoadjuvant therapy for triple-negative breast cancer.

NCT Number	NCT07523789
Lead Sponsor	The First Affiliated Hospital with Nanjing Medical University
Conditions	TNBC, Triple Negative Breast Cancer
Enrollment	201 participants
Start Date	2026-05-01
Primary Completion	2027-02-01 (estimated)
Study Completion	2027-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-13